Urticarial Vasculitis: Expert Guide To Diagnosis And Treatment
Comprehensive guide to urticarial vasculitis: symptoms, diagnosis, causes, and effective treatment strategies for this rare skin condition.

Urticarial vasculitis is a rare inflammatory disorder characterized by hive-like lesions resulting from inflammation of small blood vessels in the skin. Unlike ordinary urticaria (hives), these lesions persist longer and may indicate underlying systemic issues.
What is urticarial vasculitis?
Urticarial vasculitis represents a clinicopathological entity bridging urticaria and vasculitis. It manifests as recurrent episodes of urticarial eruptions due to leukocytoclastic vasculitis affecting postcapillary venules in the dermis. This condition can be normocomplementaemic (normal complement levels) or hypocomplementaemic (low complement levels), with the latter often linked to more severe systemic involvement.
The disease affects small vessels primarily in the skin but can extend to other organs, leading to a spectrum of presentations from purely cutaneous to multisystem disease. It is often chronic or recurrent, with wheals accompanied by burning pain rather than typical itchiness.
Who gets urticarial vasculitis?
Urticarial vasculitis is uncommon, with an estimated prevalence lower than that of chronic spontaneous urticaria. It typically affects adults aged 30-50 years, with a slight female predominance, particularly in hypocomplementaemic forms associated with autoimmune diseases.
Individuals with connective tissue diseases, such as systemic lupus erythematosus (SLE), are at higher risk. Other associations include infections (e.g., hepatitis B/C, parvovirus), medications (e.g., antibiotics, diuretics), and paraproteinaemias. Idiopathic cases remain common.
What causes urticarial vasculitis?
The aetiology is multifactorial and often idiopathic. Known triggers include:
- Autoimmune diseases: Especially SLE (up to 50% of hypocomplementaemic cases), Sjögren syndrome, rheumatoid arthritis.
- Infections: Viral (hepatitis, HIV), bacterial (streptococcus), parasitic.
- Drugs: Penicillins, sulfonamides, serum sickness reactions.
- Malignancies: Lymphoproliferative disorders, solid tumours.
- Other: Hypocomplementaemic urticarial vasculitis syndrome (HUVS), a rare severe form with anti-C1q antibodies.
Pathogenesis involves immune complex deposition in vessel walls, activating complement and neutrophils, leading to leukocytoclasia and vessel damage.
What are the clinical features of urticarial vasculitis?
The hallmark is urticarial lesions that differ from simple hives:
- Red macules, patches, or plaques (1-5 cm), often with pale centres.
- Painful or burning sensation (more common than itch).
- Persist >24 hours (up to 72 hours), in fixed locations.
- Resolve with purpura, ecchymoses, or hyperpigmentation.
Systemic features occur in 30-50% of cases, more frequent in hypocomplementaemic type:
- Musculoskeletal: Arthralgias/myalgias (50-60%).
- Respiratory: Angioedema (40%), dyspnoea, pleural effusions.
- Gastrointestinal: Abdominal pain, nausea.
- Renal: Glomerulonephritis (rare, but serious).
- Other: Fever, lymphadenopathy, uveitis, pericarditis.
HUVS may include anti-C1q antibodies and chronic obstructive pulmonary disease-like symptoms.
How is urticarial vasculitis diagnosed?
Diagnosis combines clinical features, histopathology, and lab tests to exclude mimics like chronic urticaria.
Clinical criteria: Persistent wheals >24h, pain/burning, post-lesional pigmentation.
Skin biopsy (gold standard): Early lesion shows leukocytoclastic vasculitis – neutrophilic infiltrate, karyorrhexis, fibrinoid necrosis, erythrocyte extravasation. Direct immunofluorescence (DIF) may reveal complement deposition.
| Histological Feature | Description |
|---|---|
| Endothelial swelling | Luminal narrowing |
| Neutrophilic karyorrhexis | Nuclear dust |
| Fibrinoid necrosis | Vessel wall damage |
| Erythrocyte extravasation | Purpura formation |
Laboratory investigations:
- Complement levels (C3, C4, C1q) – low in 40-50%.
- Anti-C1q antibodies (specific for HUVS).
- A autoantibodies: ANA, anti-dsDNA (SLE screen).
- Urinalysis, renal function, inflammatory markers (ESR, CRP).
- Infection/malignancy screen: Hepatitis serology, SPEP.
Dermoscopy aids in detecting subtle purpura.
What is the differential diagnosis for urticarial vasculitis?
- Chronic spontaneous urticaria: Itchy, resolves <24h, no vasculitis on biopsy.
- Urticarial dermatoses: Mastocytosis, Schnitzler syndrome.
- Other vasculitides: Cryoglobulinaemia, Henoch-Schönlein purpura.
- Infections: Erythema multiforme.
- SLE: Photosensitive rash.
What is the treatment for urticarial vasculitis?
Treatment is tailored to severity: cutaneous vs. systemic. No FDA-approved specific therapies; evidence is from case series.
Mild cutaneous disease:
- Antihistamines (H1 blockers, e.g., cetirizine) for symptom relief.
- NSAIDs (indomethacin, ibuprofen).
First-line agents:
- Dapsone (50-200 mg/day).
- Colchicine (0.6-1.2 mg/day).
- Hydroxychloroquine (200-400 mg/day), especially if SLE-associated.
- Antibiotics (doxycycline 100 mg BID).
Severe or refractory:
- Oral corticosteroids (prednisone 0.5-1 mg/kg).
- Immunosuppressants: Methotrexate, azathioprine, mycophenolate, cyclosporine.
- Biologics: Rituximab, omalizumab, IL-1 inhibitors (anakinra).
Treat underlying causes (e.g., infection, SLE). Monitor for organ involvement.
What is the outcome for urticarial vasculitis?
Prognosis varies: 30-40% resolve within 1 year; others chronic/recurrent over years. Skin-limited cases have excellent outcomes. Systemic forms, especially HUVS, carry risks of renal/pulmonary disease (mortality <10% with treatment).
Monitoring: Regular clinical assessment, labs for flares. Patient education on triggers (infections, stress).
Complications
- Chronic pigmentation/scarring.
- Renal failure (rare).
- COPD-like lung disease in HUVS.
- Secondary infections.
Prevention
Avoid triggers: NSAIDs if intolerant, infections via vaccination. Prompt flare treatment.
Frequently Asked Questions
What does urticarial vasculitis look like?
Hive-like red wheals lasting >24 hours, painful, resolving with bruising.
Is urticarial vasculitis dangerous?
Usually not; skin-limited cases are benign. Systemic involvement requires monitoring.
How long does urticarial vasculitis last?
Lesions 1-3 days; disease may last weeks to years.
Can urticarial vasculitis be cured?
Many remit spontaneously; chronic cases managed long-term.
Does urticarial vasculitis itch?
Less than hives; more burning/painful.
References
- Urticarial Vasculitis Overview — RheumNow. 2023. https://rheumnow.com/news/urticarial-vasculitis-overview
- Urticarial vasculitis — PubMed Central (NIH). 2021-07-01. https://pmc.ncbi.nlm.nih.gov/articles/PMC8243153/
- Urticarial Vasculitis — Vasculitis UK. 2024. https://www.vasculitis.org.uk/about-vasculitis/urticarial-vasculitis
- Urticarial Vasculitis — Vasculitis Foundation. 2023. https://vasculitisfoundation.org/education/vasculitis-types/urticarial-vasculitis/
- Urticarial vasculitis — DermNet NZ. 2024. https://dermnetnz.org/topics/urticarial-vasculitis
Read full bio of medha deb














